| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | LOXO ONCOLOGY INC COM | 250,000 | 6,835,000 | 7.85% | ||
| 2 | EPIZYME INC COM | 545,000 | 6,605,000 | 7.58% | ||
| 3 | FOUNDATION MEDICINE INC COM | 335,000 | 6,090,000 | 6.99% | ||
| 4 | SAGE THERAPEUTICS | 189,000 | 6,059,000 | 6.95% | ||
| 5 | AGIOS PHARMACEUTICALS INC | 148,000 | 6,009,000 | 6.90% | ||
| 6 | BLUEPRINT MEDICINES CORP COM | 321,300 | 5,799,000 | 6.66% | ||
| 7 | ALNYLAM PHARMACEUTICALS INC | 90,000 | 5,649,000 | 6.48% | ||
| 8 | BLUEBIRD BIO INCORPORATED | 120,000 | 5,100,000 | 5.85% | ||
| 9 | MYOKARDIA INC | 475,350 | 5,091,000 | 5.84% | ||
| 10 | SPARK THERAPEUTICS INC | 170,000 | 5,017,000 | 5.76% | ||
| 11 | CYTOMX THERAPEUTICS INC COM | 321,023 | 4,141,000 | 4.75% | ||
| 12 | KITE PHARMA INCORPORATED | 75,000 | 3,443,000 | 3.95% | ||
| 13 | VOYAGER THERAPEUTICS INC | 339,362 | 2,963,000 | 3.40% | ||
| 14 | EDITAS MEDICINE INCORPORATED | 85,470 | 2,952,000 | 3.39% | ||
| 15 | DEXCOM | 40,000 | 2,716,000 | 3.12% | ||
| 16 | SPDR SER TR | 50,000 | 2,583,000 | 2.96% | Put | |
| 17 | AVEXIS INC COM | 63,000 | 1,716,000 | 1.97% | ||
| 18 | GLOBAL BLOOD THERAPEUTICS IN COM | 105,000 | 1,665,000 | 1.91% | ||
| 19 | GENOMIC HEALTH INC COM | 55,000 | 1,362,000 | 1.56% | ||
| 20 | BRISTOL MYERS SQUIBB CO | 21,000 | 1,341,000 | 1.54% | ||
| 21 | BIOGEN INC | 5,000 | 1,302,000 | 1.49% | ||
| 22 | BEIGENE LTD | 32,500 | 953,000 | 1.09% | ||
| 23 | IGNYTA INC COM | 110,000 | 745,000 | 0.86% | ||
| 24 | EXACT SCIENCES CORP | 60,000 | 404,000 | 0.46% | ||
| 25 | MEDIDATA SOLUTIONS INC | 10,000 | 387,000 | 0.44% | ||
| 26 | Oxford Immunotec Global PLC | 20,000 | 198,000 | 0.23% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-003186, filed 2016.05.09).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
